Dengue viruses exhibit strain-specific infectivity and entry requirements in vitro
Author(s): Barr KL | Anderson BD
Volume: 2013
Issue: default
Year: 2013
Author(s): Barr KL | Anderson BD Volume: 2013 Issue: default Year: 2013
Schmallenberg virus: continuing a trend?
Author(s): Noad R | Brownlie J
Volume: 2013
Issue: default
Year: 2013
Author(s): Noad R | Brownlie J Volume: 2013 Issue: default Year: 2013
Dengue serotypes 1–4 exhibit unique host specificity in vitro
Author(s): Barr KL | Anderson BD | Heil GL | Friary JA | Gray GC | Focks DA
Volume: 2012
Issue: default
Year: 2012
Author(s): Barr KL | Anderson BD | Heil GL | Friary JA | Gray GC | Focks DA Volume: 2012 Issue: default Year: 2012
Oncolytic viruses: a step into cancer immunotherapy
Author(s): Pol JG | Rességuier J | Lichty BD
Volume: 2012
Issue: default
Year: 2011
Author(s): Pol JG | Rességuier J | Lichty BD Volume: 2012 Issue: default Year: 2011
Mapping protein–RNA interactions
Author(s): Vaughan R | Running W | Qi R | Kao CC
Volume: 2012
Issue: default
Year: 2012
Author(s): Vaughan R | Running W | Qi R | Kao CC Volume: 2012 Issue: default Year: 2012
Abortive lytic Epstein–Barr virus replication in tonsil-B lymphocytes in infectious mononucleosis and a subset of the chronic fatigue syndrome
Author(s): Lerner AM | Beqaj S
Volume: 2012
Issue: default
Year: 2012
Author(s): Lerner AM | Beqaj S Volume: 2012 Issue: default Year: 2012
New agents for the treatment of hepatitis C virus – focus on telaprevir
Author(s): Thompson AJ | Patel K
Volume: 2012
Issue: default
Year: 2012
Author(s): Thompson AJ | Patel K Volume: 2012 Issue: default Year: 2012
Effect of hepatitis C virus on the central nervous system of HIV-infected individuals
Author(s): Gess M | Forton D
Volume: 2012
Issue: default
Year: 2012
Author(s): Gess M | Forton D Volume: 2012 Issue: default Year: 2012
Issues in resistance, adherence, and comparative efficacy of the single-tablet regimen combination of tenofovir, emtricitabine, and efavirenz in the management of HIV-1 infection
Author(s): Rebick G | Walmsley SL
Volume: 2012
Issue: default
Year: 2012
Author(s): Rebick G | Walmsley SL Volume: 2012 Issue: default Year: 2012
A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome
Author(s): A Martin Lerner | Safedin Beqaj
Volume: 2011
Issue: default
Year: 2011
Author(s): A Martin Lerner | Safedin Beqaj Volume: 2011 Issue: default Year: 2011
Evolution and adaptation of the pandemic A/H1N1 2009 influenza virus
Author(s): Ducatez MF | Fabrizio TP | Webby RJ
Volume: 2011
Issue: default
Year: 2011
Author(s): Ducatez MF | Fabrizio TP | Webby RJ Volume: 2011 Issue: default Year: 2011
The management of herpes simplex virus infections in HIV infected patients: current issues and the role of cidofovir
Author(s): Nakakawa E | Reynolds SJ
Volume: 2011
Issue: default
Year: 2011
Author(s): Nakakawa E | Reynolds SJ Volume: 2011 Issue: default Year: 2011
Boceprevir in the treatment of chronic hepatitis C virus infection
Author(s): Marina Berenguer | F Xavier López-Labrador
Volume: 2011
Issue: default
Year: 2011
Author(s): Marina Berenguer | F Xavier López-Labrador Volume: 2011 Issue: default Year: 2011
Acyclovir and hydrocortisone cream for the early treatment of recurrent cold sores
Author(s): Carrie A Sailer | Spotswood L Spruance | Christopher M Hull
Volume: 2011
Issue: default
Year: 2011
Author(s): Carrie A Sailer | Spotswood L Spruance | Christopher M Hull Volume: 2011 Issue: default Year: 2011
The impact of hypoxia on oncolytic virotherapy
Author(s): Guo ZS
Volume: 2011
Issue: default
Year: 2011
Author(s): Guo ZS Volume: 2011 Issue: default Year: 2011
Critical appraisal and update on tenofovir in management of human immunodeficiency virus infection
Author(s): Alvarez E | Morello J | Soriano V | Labarga P | Rodriguez-Nóvoa S
Volume: 2011
Issue: default
Year: 2011
Author(s): Alvarez E | Morello J | Soriano V | Labarga P | Rodriguez-Nóvoa S Volume: 2011 Issue: default Year: 2011
Clinical utility and long-term use of atazanavir in the treatment of HIV-1 infection
Author(s): Rampling T | Nelson M
Volume: 2011
Issue: default
Year: 2011
Author(s): Rampling T | Nelson M Volume: 2011 Issue: default Year: 2011
An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies
Author(s): S Chinnaswamy | H Cai | C Kao
Volume: 2010
Issue: default
Year: 2010
Author(s): S Chinnaswamy | H Cai | C Kao Volume: 2010 Issue: default Year: 2010
Poxviruses: smallpox vaccine, its complications and chemotherapy
Author(s): Mimi Remichkova
Volume: 2010
Issue: default
Year: 2010
Author(s): Mimi Remichkova Volume: 2010 Issue: default Year: 2010
Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
Author(s): A Martin Lerner | Safedin Beqaj | James T Fitzgerald | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): A Martin Lerner | Safedin Beqaj | James T Fitzgerald | et al Volume: 2010 Issue: default Year: 2010
p38 and STAT3 activation by vGPCR in KSHV-infected cells
Author(s): Mingli Liu | Shanchun Guo
Volume: 2010
Issue: default
Year: 2010
Author(s): Mingli Liu | Shanchun Guo Volume: 2010 Issue: default Year: 2010
Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae
Author(s): Darci R Smith | Monica Ogg | Aura Garrison | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Darci R Smith | Monica Ogg | Aura Garrison | et al Volume: 2010 Issue: default Year: 2010
Viral vectors for cystic fibrosis gene therapy: What does the future hold?
Author(s): Uta Griesenbach | Makoto Inoue | Mamoru Hasegawa | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Uta Griesenbach | Makoto Inoue | Mamoru Hasegawa | et al Volume: 2010 Issue: default Year: 2010
Antibody targeting of TSG101 on influenza-infected cells
Author(s): Aurelio Bonavia | Leyla S Diaz | David Santos | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Aurelio Bonavia | Leyla S Diaz | David Santos | et al Volume: 2010 Issue: default Year: 2010
Conformations of the monomeric hepatitis C virus RNA-dependent RNA polymerase
Author(s): Sreedhar Chinnaswamy | Ayaluru Murali | Hui Cai | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Sreedhar Chinnaswamy | Ayaluru Murali | Hui Cai | et al Volume: 2010 Issue: default Year: 2010
Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease
Author(s): J Ortiz-Alcantara | K Bhardwaj | S Palaninathan | et al.
Volume: 2010
Issue: default
Year: 2010
Author(s): J Ortiz-Alcantara | K Bhardwaj | S Palaninathan | et al. Volume: 2010 Issue: default Year: 2010
The next generation: etravirine in the treatment of HIV-1 infection in adults refractory to other antiretrovirals
Author(s): R Chris Rathbun | Michelle D Liedtke
Volume: 2010
Issue: default
Year: 2010
Author(s): R Chris Rathbun | Michelle D Liedtke Volume: 2010 Issue: default Year: 2010
An update on the management of glandular fever (infectious mononucleosis) and its sequelae caused by Epstein–Barr virus (HHV-4): new and emerging treatment strategies
Author(s): A Martin Lerner | Safedin H Beqaj | Ken Gill | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): A Martin Lerner | Safedin H Beqaj | Ken Gill | et al Volume: 2010 Issue: default Year: 2010
Differential susceptibility of HIV strains to innate immune factors in human cervical-vaginal secretions
Author(s): Mimi Ghosh | John V Fahey | Charles R Wira
Volume: 2010
Issue: default
Year: 2010
Author(s): Mimi Ghosh | John V Fahey | Charles R Wira Volume: 2010 Issue: default Year: 2010
The role of herpesviruses in ocular infections
Author(s): Asim V Farooq | Arpeet Shah | Deepak Shukla
Volume: 2010
Issue: default
Year: 2010
Author(s): Asim V Farooq | Arpeet Shah | Deepak Shukla Volume: 2010 Issue: default Year: 2010
A method for evaluating antiviral drug susceptibility of Epstein-Barr virus
Author(s): Charlotte A Romain | Henry H Balfour Jr | Heather E Vezina | et al
Volume: 2010
Issue: default
Year: 2010
Author(s): Charlotte A Romain | Henry H Balfour Jr | Heather E Vezina | et al Volume: 2010 Issue: default Year: 2010
Resistance patterns and genetic variations in patients with hepatitis C virus: emerging role of telaprevir
Author(s): C Argentini | D Genovese | S Catone
Volume: 2010
Issue: default
Year: 2010
Author(s): C Argentini | D Genovese | S Catone Volume: 2010 Issue: default Year: 2010
Tenofovir: A new option for the treatment of chronic hepatitis B
Author(s): Walid S Ayoub
Volume: 2009
Issue: default
Year: 2009
Author(s): Walid S Ayoub Volume: 2009 Issue: default Year: 2009
HIV-1 evolution, drug resistance, and host genetics: The Indian scenario
Author(s): U Shankarkumar | A Pawar | K Ghosh
Volume: 2009
Issue: default
Year: 2009
Author(s): U Shankarkumar | A Pawar | K Ghosh Volume: 2009 Issue: default Year: 2009
A critical appraisal of Ixiaro® – a cell-derived inactivated vaccine for Japanese encephalitis
Author(s): Taff Jones
Volume: 2009
Issue: default
Year: 2009
Author(s): Taff Jones Volume: 2009 Issue: default Year: 2009